Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker FDA Class II Recalls Reported (recalls) by Year
Stryker FDA Class II Recalls Reported (recalls): 26 in FY2025, down 35.0% from a year earlier.
Latest, FY2025
26
Period ended Dec 31, 2025
Change on a year earlier
-35.0%
40 in FY2024
History
8 years
Since FY2018
Sources
4
Documents cited below
Where the FY2025 figure comes from
Reported in Stryker Comprehensive Reports (2021–2025).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | FDA Class II Recalls Reported (recalls) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 26 | -35.0% | 2025 Comprehensive Report (ir|comp_report_2025) ↗ |
| FY2024 | Dec 31, 2024 | 40 | +14.3% | 2025 Comprehensive Report (ir|comp_report_2025) ↗ |
| FY2023 | Dec 31, 2023 | 35 | +29.6% | 2025 Comprehensive Report (ir|comp_report_2025) ↗ |
| FY2022 | Dec 31, 2022 | 27 | -3.6% | 2023 Comprehensive Report (ir|comp_report_2023) ↗ |
| FY2021 | Dec 31, 2021 | 28 | +64.7% | 2023 Comprehensive Report (ir|comp_report_2023) ↗ |
| FY2020 | Dec 31, 2020 | 17 | -39.3% | 2022 Comprehensive Report (ir|comp_report_2022) ↗ |
| FY2019 | Dec 31, 2019 | 28 | -33.3% | 2022 Comprehensive Report (ir|comp_report_2022) ↗ |
| FY2018 | Dec 31, 2018 | 42 | – | 2021 Comprehensive Report (ir|comp_report_2021) ↗ |
Cite this data
StockData. (2026). Stryker FDA Class II Recalls Reported (recalls), annual FY2018–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/qual-rec-c2
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.